Verified Document

Drug Manufacturers And The Threat Of Me Too Drug Makers Essay

Patent Exclusivity I would propose modifying the development and/or regulatory review processes to help reverse the trend towards "me too" drugs by overhauling the system that allows for drug companies to "chemically rejigger an oldie but goodie, craft a new name, mount a massive advertising campaign and sell the retread as the latest innovative breakthrough" (Mattina, 2015). The overhaul would require companies to show how their new "innovation" is different from a previous drug and what makes it more beneficial. These re-inventions of the wheel allow companies to skate past competitors who heavily invest in actually innovative drug developments by reaping the spoils of their labor after simply altering a chemical or two and claiming the innovation for themselves. In order to level the playing field and make it more of a fair practice for every company, there needs to be a system of reporting that validates and justifies the changes made to a formula before the company can proceed to market. This will eliminate the entire sector for "me too" drugs. If companies cannot show how they are bettering a formula (as opposed to simply making it different), then the review board will have no choice but to reject...

This will encourage actual innovation rather than just the piggy-backing practices of the "me too" industry.
As DiMasi, Hansen and Grabowski (2003) show, the price of innovation is the actual issue in today's drug market. Costs are soaring and that is reflected in the price of pharmaceuticals on the market. Thus, in order to optimize the period of a developer's patent exclusivity without compromising public health and safety, I would suggest that the review board disallow competitors from essentially "stealing" the innovative formula of the company's success and barring "me too" drugs from hitting the market until the time in which the patent is in its last 5 years. Some might argue that this is manipulation of a free market system and that it will lead to monopolies and higher prices, but if a company is invested in a product it has a right to reap the rewards of its hard work and not see them despoiled by others who simply sit back and wait to steal the formula for their own profits.

Concerns about health and safety may be an issue for some consumers, however; and therefore regulations should also be geared towards optimizing the innovation and testing of these…

Sources used in this document:
References

DiMasi, J., R. W. Hansen, H. G. Grabowski, 2003 "The price of innovation: new estimates of drug development costs," Journal of Health Economics 22: 151-185.

Mattina, J. (2015). Impact of 'me-too' drugs on health care costs. Forbes. Retrieved from http://www.forbes.com/sites/johnlamattina/2015/01/19/impact-of-me-too-drugs-on-health-care-costs/#3070fdeb2610
Cite this Document:
Copy Bibliography Citation

Related Documents

Generic Drugs
Words: 3188 Length: 10 Document Type: Term Paper

India Pharma Mfg Many Americans have responded to the high prices on U.S. pharmaceuticals by purchasing them from other countries. Several countries have built cottage industries around shipping drugs to the United States. Initially, Canada was a favored country for this, given the reliability of drugs coming from Canada. However, price caps or not Canada still has Western prices for its pharmaceuticals, which has led to buyers searching the world for

Resolving the Higher Prescriptive Drug Cost Problem
Words: 1450 Length: 5 Document Type: Term Paper

Resolving the Higher Prescriptive Drug Cost Problem Resolving beneficiary or medical consumer issues with respect to the rapidly rising costs of drugs is a heated issue I government and in every American's living room. Not only are those living in assisted living facilities but also parents with children and the increased number of retiring baby boomers are being financially affected in significant ways. In addition those Americans without proper insurance coverage

Direct to Consumer Advertising History of Drug
Words: 16271 Length: 59 Document Type: Term Paper

Direct to Consumer Advertising HISTORY OF DRUG ADVERTISING THE DTC ADVERTISING PHENOMENON CREATING DEMAND DECEPTIVE ADVERTISING - A WOLF IN SHEEP'S CLOTHING CAUSE OF DEATH PROFIT UTILIZATION, PRICING, AND DEMOGRAPHICS LEGISLATION, POLITICS AND PATENTS LEGISLATIVE INITIATIVES REGARDING DTC RECALLED and/or DEADLY DRUGS In order to provide the most efficient method of evaluation, the study will utilize existing stores of qualitative and quantitative data from reliable sources, such as U.S. Government statistical references, University studies, and the studies and publications of non-profit

Business Ethics in Drug Companies
Words: 3262 Length: 9 Document Type: Term Paper

Office Memo Sub: comment on John's claim as a whistle blower against PharmaCARE and the ethical and legal implications of the case As a member of Dewey, Chetum, and Howe you asked me to find out suitable ethical and legal implications that John's case could bring for the firm and for John himself. Detailed in the report are the issues regarding: The Ethical issues relating to marketing and advertising, intellectual property, and regulation

Japanese-American Biopharmaceutical Industry in the 21st Century
Words: 20340 Length: 60 Document Type: Term Paper

Japanese-American Biopharmaceutical Industry in the 21st Century Optimizing Ethical Drug Availability Between These Two Pharmaceutical Superpowers" The Japanese-American biopharmaceutical industry represents an ongoing international effort between the two top pharmaceutical markets in the world. These two economic powers provide consumers with a majority share of all pharmaceuticals produced in the world. However, a number of pharmaceutical products that are currently available to U.S. residents are unavailable to Japanese consumers. From a humanitarian perspective, this

Budgetary Politics
Words: 5817 Length: 18 Document Type: Term Paper

Budgetary Politics The United States of America has long grappled with the problem of drugs and has form time to time initiated measures to combat the usage and trafficking of drugs. It is common knowledge that the various wars that have been part of the combat program of several administrations have failed miserably despite the availability of a great deal of resources, added to the colossal funding process. This is in

Sign Up for Unlimited Study Help

Our semester plans gives you unlimited, unrestricted access to our entire library of resources —writing tools, guides, example essays, tutorials, class notes, and more.

Get Started Now